Wu, S., Xu, J., Li, Y., & Yu, D. (2026). Prognostic Value of Baseline Systemic Immune-Inflammation Index in Advanced Intrahepatic Cholangiocarcinoma Treated with First-Line Gemcitabine–Cisplatin Plus PD-L1 Inhibitor: A Single-Center Retrospective Study. Current Oncology, 31(2), 123-138.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
Wu, Shuan, Jiawei Xu, Yan Li, and Decai Yu. "Prognostic Value of Baseline Systemic Immune-Inflammation Index in Advanced Intrahepatic Cholangiocarcinoma Treated with First-Line Gemcitabine–Cisplatin Plus PD-L1 Inhibitor: A Single-Center Retrospective Study."
Current Oncology 31, no. 2 (2026): 123-138.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
Wu, Shuan, et al. "Prognostic Value of Baseline Systemic Immune-Inflammation Index in Advanced Intrahepatic Cholangiocarcinoma Treated with First-Line Gemcitabine–Cisplatin Plus PD-L1 Inhibitor: A Single-Center Retrospective Study."
Current Oncology, vol. 31, no. 2, 2026, pp. 123-138.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.